KPRX שווי כולל של נכסי החברה Kiora Pharma

Kiora Pharmaceuticals (KPRX) is implementing automated data analysis systems for retinal pathologies and robotic compound screening. The business relies on the development of ophthalmological agents in the US and strategic collaboration with Western clinics, with total assets amounting to 27.87. This price action visualized on the GURU.Markets platform complements information regarding the development of innovative photoswitches to combat blindness.

The stable operation of ophthalmology laboratories and equipment modernization at Kiora Pharmaceuticals (KPRX) are directly capitalized into total assets, which are reverse-calculated here via ROA to determine the company's total resource value. This metric measures the aggregate asset base and liabilities, allowing investors to use the total asset value to assess the risk of overpaying for an overheated business when buying at historical peaks.